You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Novo Nordisk Articles
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Send a link to this page to your friends and colleagues.
Taking rapid-acting insulin before meals may reduce major incidents of nighttime hypoglycemia and minor incidents of daytime hypoglycemia, according to research conducted by Novo Nordisk presented at the ADA's scientific sessions in June.
Investigators observed the effects of insulin aspart (Novolog), a rapid-acting insulin, as compared to a soluble, regular-acting human insulin on 155 type 1 subjects over two 16-week periods. Both groups maintained an intensive basal bolus insulin regimen, taking either Novolog or human insulin before meals, then injecting NPH after meals once or twice daily, as needed, to keep tight control of their blood sugars.
There were 72 percent fewer episodes of major nighttime and somewhat fewer events of minor daytime hypoglycemia in the group who took the rapid-acting insulin before meals as compared to those who took the regular-acting insulin.
0 comments - Aug 1, 2001
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.